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Abstract
MicroRNAs (miRNAs) are present in all known plant and animal tissues and appear to be somewhat
concentrated in the mammalian nervous system. Many different miRNA expression profiling
platforms have been described. However, relatively little research has been published to establish
the importance of ‘upstream’ variables in RNA isolation for neural miRNA expression profiling. We
tested whether apparent changes in miRNA expression profiles may be associated with tissue
processing, RNA isolation techniques, or different cell types in the sample. RNA isolation was
performed on a single brain sample using eight different RNA isolation methods, and results were
correlated using a conventional miRNA microarray and then cross-referenced to Northern blots.
Differing results were seen between samples obtained using different RNA isolation techniques and
between microarray and Northern blot results. Another complication of miRNA microarrays is tissue-
level heterogeneity of cellular composition. To investigate this phenomenon, miRNA expression
profiles were determined and compared between highly-purified primary cerebral cortical cell
preparations of rat primary E15–E18 neurons versus rat primary E15–E18 astrocytes. Finally, to
assess the importance of dissecting human brain gray matter from subjacent white matter in cerebral
cortical studies, miRNA expression profiles were compared between gray matter and immediately
contiguous white matter. The results suggest that for microarray studies, cellular composition is
important, and dissecting white matter from gray matter improves the specificity of the results. Based
on these data, recommendations for miRNA expression profiling in neural tissues, and considerations
worthy of further study, are discussed.
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Introduction
MicroRNAs (miRNAs) are short regulatory RNAs that play important biological roles in plants
and animals alike [1]. In mammals, there appears to be a concentration of miRNAs in the brain
[2–5]. MiRNAs in brain have been implicated in many fundamental functions including
neurodevelopment, plasticity, and apoptosis (see reviews [6,7]). Furthermore, miRNA
dysfunction has been implicated in brain cancers, neurodegeneration, and schizophrenia [8–
11]. These are among the reasons that researchers have been interested in obtaining miRNA
profiling data from neural tissues.
Many miRNA profiling platforms and techniques have been used to assay the miRNA
repertoire of biological samples. Platforms have incorporated cloning, microarrays, PCR, high-
throughput Northern blots, nanoscale technologies, and other modalities [2–4,12–29]. Each
technique presumably entails specific strengths and weaknesses, including sensitivity,
specificity, and cost-related considerations.
While the miRNA expression profiling platforms have received considerable interest, less
attention has been focused on the ‘upstream’ steps of miRNA expression profiling: tissue
selection, tissue dissection, and RNA isolation. Yet these pre-analytical steps are very
important. When isolating RNA from cells or tissues, there are many potential opportunities
for the introduction of systematic bias and/or experimental error. Some of these have been
shown to be important in human studies regarding mRNA integrity (see for example [30–
35]), however, systematic studies of pre-analytical variables for miRNA expression have not
been published. For studies of human brain tissue, important variables include pre-mortem
factors, as well as autopsy conditions, tissue dissection technique, and RNA isolation
technique.
We assessed preliminarily the effects on apparent miRNA repertoires (as quantified by a
conventional miRNA microarray and Northern blotting) that may be associated with tissue
processing, RNA isolation techniques, and the identity of the neuroepithelial cell types in the
sample. It should be stressed that these experiments are just an initial effort because much
additional work needs to be performed to assess the nature and degree of changes in a miRNA-
containing sample that are brought about merely by the techniques with which the RNA is
isolated. Furthermore, each expression profiling platform will have unique issues. With those
caveats, considerations worthy of further study are discussed.
Methods
RNA isolation from a human cerebral cortex using different methods
All RNA isolation methods were used on powdered brain (91 y.o.non-demented female, post-
mortem interval 1.75 hours; neuropathology from subjacent tissue showed very minimal
cortical Alzheimer’s-type pathology which is usual for the patient’s age) from superior and
middle temporal cortical tissue which was prepared thusly: Tissue (6 gms) that had been snap-
frozen in liquid nitrogen (LN) and then transferred to a −80C freezer was placed in an RNAse-
free pestle and bathed in LN, and then ground to fine powder in LN for ten minutes with multiple
changes of LN. Homogeneously powdered tissue in LN was then transferred to a −80C freezer
without ever having thawed. Tissue for RNA isolation was directly placed in lysis buffers (see
below) for the subsequent RNA isolation. Trizol LS (Invitrogen) was the only technique that
did not specify or provide a specific lysis buffer. We performed one set of experiments with
the exact protocol given in the Trizol LS instructions, and one experiment with an additional
overnight −20C precipitation step. MiRVANA kit: after homogenization as described above,
we isolated small, large, and total RNA exactly as described in the manufacturer’s protocol.
Stratagene total RNA and microRNA: the same as the protocol, except for the homogenization
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caveat above. Performing the Qiagen RNeasy was unsuccessful when we used the needle
homogenization technique as described in the manufacturer’s protocol, so a dounce-type
homogenizer was employed instead with success.
RNA isolation from tissue cultured cells
RNA was isolated from primary rat cultures (embryonic day 15–18) that were highly purified
(>98%) for either hippocampal neurons, or cerebral cortical astrocytes. Cells were purified and
cultured using conventional methods as described previously [36–38]. Cells were washed in
PBS, scraped in PBS, and then total RNA was isolated using Trizol LS as described above
according to manufacturer’s protocol. For the studies involving H4 glioneuronal tumor-derived
cell line [39,40], the cells were cultured in conditions as per their vendor (ATCC, Inc.) and
harvested at ~80% confluencein a 100cm culture dish. Cells were washed in PBS, collected in
PBS, and RNA was isolated using Trizol LS according to manufacturer’s recommended
protocol.
RNA isolation from gray matter and subjacent white matter
RNA was isolated from gray matter and white matter immediately subjacent under RNAse-
free conditions. For this experiment, the superior and mid-temporal isocortex was obtained
after having been snap-frozen in LN from three different patients with similar clinical histories
from the University of Kentucky ADC (Alzheimer’s Disease Center) Brain Bank: a 93 year
old female (Patient 1); an 84-year old female (Patient 2); and a 90 year old female (Patient 3).
A razor blade was used to quickly separate the two different tissues, (<500mg each) which
were then each homogenized using a Dounce-type glass and Teflon homogenizer on ice. Total
RNA was isolated from the homogenate using Trizol LS as described above according to the
manufacturer’s protocol. RNA was analyzed using the Agilent Bioanalyzer.
Microarray methods and analyses
The mercury Labeling Kit (Exiqon) was used for target labeling and hybridization to a
conventional miRNA microarray. The oligonucleotide probe arrays were printed on Codelink
substrates, processed and scanned at the University of Pennyslvania Microarray Core Facility.
The protocols used are indicated in Supplementary File #1. R-squared values were calculated
(and charted) using Log(10) values of the raw microarray data.
Northern blots
Northern blot analysis: 10 µg of total RNA, and the equivalent total small RNA isolated from
the same quantity of tissue was separated on a denaturing 15% polyacrylamide gel and
transferred electrophoretically to a Hybond-N-Nylon filter membrane. After transfer, the
membrane was soaked briefly in 2XSSPE, and was cross-linked using a UV cross-linker.
Specific miRNA probes using their antisense DNA oligonucleotides were labeled by T4
polynucleotide kinase with 30 µCi gamma-32P-dATP (6000 Ci/mmole). The membrane was
first prehybridized in a hybridization buffer (50% formamide, 5X SSPE, 5X Denhardt’s, 0.5%
SDS, 80 µg/ml shark sperm DNA)for at least 2 hr at 37 °C, follow by hybridization with a
specific probe for 6 hr to overnight. Afterwards, the membrane was washed 2–3 times with 2X
SSC containing 0.1% SDS for 20 min at the same temperature. The membranes were wrapped
and exposed to a phosphor-storage screen. The signals were detected by scanning the phosphor-
storage screen using a phosphorimager scanner (Typhoon 9400, Molecular Dynamics, GE
Healthcare Bio-Sciences, Piscataway, NJ). The detected signals were quantified using
ImageQuant TL software (Amersham Biosciences, Piscataway, NJ), and normalized against
the signal intensity of 5SrRNA by ethidium bromide gel staining. The membrane was stripped
and subsequently hybridized with other miRNA probes.
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Results
RNA isolation – effect on RNA quality parameters
The same starting material was used for each isolation technique (see above for detailed
description). The different RNA isolation techniques (Table 1) were chosen to include widely-
used methods, associated with manufacturers’ supplied protocols, that incorporated different
one-step biochemical principles (e.g., phenol/chloroform and resin-based columns, total RNA
versus large or small RNA). PAGE-based RNA isolation techniques were not used because
they employ a two-stage isolation strategy. The results of these experiments can be described
in terms of RNA quality parameters; miRNA expression profiling results; and the relationship
between the microarray results and Northern blots results (See Table 1, Figure 1–Figure 2, and
Supplementary File 1–Supplementary File 5). In terms of RNA quality, Agilent Bioanalyzer
results are shown in detail in Supplementary File 2–Supplementary File 4. The Agilent
Bioanalyzer “RIN” (RNA integrity number) is measurement for degree of degradation in a
total RNA sample based on integrated Bioanalyzer signal amounts under the expected
ribosomal peaks or detected in smaller degradation products, and can be used to compare the
quality of different RNA samples. Small RNA is not correctly assessed by the RIN algorithm
and the resulting RINs should not be compared to those from total RNA.
The effect of different RNA isolation techniques on miRNA microarray results
Overall, RNA derived from a single tissue source was of differing quality depending upon the
method used to isolate it. These results are demonstrated in Table 1. However, miRNAs are
known to be relatively robust even in conditions that degrade other RNAs [42]. The important
focus of concern was whether or not different RNA isolation techniques enabled consistent
profiling results that could be validated by Northern blots. In our hands, there was little
difference in the results (either by microarray or Northern blotting) when we introduced a
longer, −20C isopropanol precipitation step in the Trizol LS processing, rather than using the
manufacturer’s protocol exactly (Figure 2). Differences were seen in A260/230 ratios that we
cannot readily explain. We included two RNA isolation methods that are nominally irrelevant
to miRNA research: Ambion large RNA and Qiagen RNeasy. These methods both extract
predominantly RNAs that are larger than miRNAs. These were included to test for unprocessed
miRNA precursors that may be present in both large RNA and total RNA samples. However,
we did not find these samples to provide contributory data. Hence, the results of the microarray
data from RNA isolations for the larger RNA methods are included (see Table 1 and
Supplemental File 5), but were not analyzed further.
In order to gain some insight into whether one or another of the RNA isolation methods was
most desirable, we used two different strategies: 1. comparing microarray results from
correlation between the different methods; and 2. comparing the microarray results from the
different methods to a different profiling method—Northern blots.
In comparing the microarray results from different isolation methods, average signals results
were used from three technical replicates of six different RNA isolation methods. The results
are shown on Figure 1 and Figure 2. The techniques that showed the higher correlation
coefficients tended to use the phenol/chloroform-based protocol (Trizol LS total and Stratagene
total RNA kits).
In comparing the microarray results from different methods to Northern blots (Figure 2), we
used only a selection of probes referent to miRNAs that were expressed at a high level by
microarray. The digested results are presented as Figure 2. The raw data of the Northern blots
and the comparison with microarray results are shown in Supplemental File 5. These results
show differences between the microarray results and the Northern blots—the Northern blot
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appeared to be somewhat more sensitive for miR-26a and less sensitive for miR-221. Also, the
pattern of relative signal strengths for the same miRNA in different extracts appeared to vary
less in the Northern blot studies in comparison to the microarray studies. These results are
discussed in greater detail below.
The importance of different cell types in the brain
Primary rat astrocytes versus neurons—Different CNS cell types express different
miRNAs [43], and we sought to query the importance of this factor in microarray analyses.
We first compared the results of miRNA expression profiling between primary rat cultured
cells (E15–18) that were highly enriched either for neurons (hippocampal rat neurons) or
astrocytes (cerebral cortical rat astrocytes). The results of these experiments are shown in
Figures 4 and 5. There was a poor correlation between the miRNA repertoire from these two
types of neuroepithelial-derived cells (Figure 3), indicating a cell type-specific expression of
miRNAs.
Since different neural cell populations show distinct miRNA profiles, we sought to test a cell
line to see if those differences could be biologically informative. We tested the H4
“glioneuronal” cell line [40]. The miRNA repertoire for H4 cells was much closer to the
miRNA repertoire of primary cultured rat astrocytes than to that of primary cultured rat
neurons. This is despite the fact that both the neuronal and astrocytes primary cells were from
rat whereas the H4 cells are a tumor cell line from humans.
Human cerebral cortical gray matter versus white matter—Gray matter and white
matter are terms that are used to distinguish areas in the CNS, as shown in Figure 4. MiRNA
expression profiles were compared from human superior and medial temporal isocortex tissue
from age-matched and clinically-matched patients from the University of Kentucky ADC Brain
Bank. Gray matter and immediately subjacent white matter were dissected from tissue portions
that had been snap-frozen in liquid nitrogen, and RNA was isolated and profiled using a
microarray as above. The results indicate that the miRNA repertoire of superficial white matter
tends to correlate across different patients to a higher degree than the miRNA repertoire
correlates with that of the immediately overlying gray matter in the same patient. Hence,
closely-juxtaposed gray matter and white matter express different miRNA profiles, and these
differences are relatively consistent between different patients.
Discussion
The details of RNA isolation can have profound -- and even surprising -- impact on
experimental results, particularly in the context of miRNA microarray data. Important focus
points include details of tissue processing, RNA isolation techniques, and the significance of
different miRNA repertoires in different neuroepithelial cell types.
A limitation of this study is that detailed analyses were performed using only a single miRNA
profiling platform. It provided a large amount of data—these results comprise dozens of
different arrays. However, there now many different miRNA profiling platforms in the
scientific community and it is impossible to predict how a particular tissue processing step will
differentially affect the results across miRNA microarray platforms, much less versus PCR-
based or sequencing-based platforms. Pre-analytical parameters must be evaluated for each
and every platform separately for this reason. Another limitation of this study was that the
neuronal and astrocyte populations that were being compared were not perfectly analogous.
The astrocytes were from cerebral isocortex and the neurons from hippocampus which is also
cortical, but somewhat distinct embryologically and cytoarchitectonically. Perhaps more
importantly, even in culture, mature astrocytes divide and neurons do not. It is likely that some
of the miRNA expression changes are more specific to dividing cells versus non-dividing cells,
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however, this difference may actually reflect the normal miRNA repertoire in situ, where,
again, astrocytes unlike neurons divide into adulthood. Another potential limitation of this
study is that some of the comparisons were made between miRNAs with paralogs. For example,
miRs-29a, -26a, and let-7a each have relatively closely-related but distinct miRNA genes in
humans. We have found large differences in reported expression for miR-29a/b, miR-26a/b,
and let-7a/b, for example, but, further work may incorporate RTqPCR to better delineate
differences in expression for these and other paralogous miRNAs.
This study focused on variables of RNA isolation, including the specific RNA isolation
technique, as well as miRNA expression differences in some of the different cell types in the
CNS, and between gray and subjacent white matter of adult humans. These data suggest that
the method used to isolate RNA can impact the results, and this effect appears to be more
marked in the context of a microarray platform than in Northern blots. These data do not in
themselves recommend a particular RNA isolation method as being absolutely ‘superior’ to
others. However, we found the application of Trizol LS somewhat easier to use with more
consistent results than other methods in obtaining total RNA. In our hands, there was only a
small difference in the results (either on microarray or Northern blotting) when we introduced
a longer, −20C alcohol precipitation step in the Trizol LS processing. As expected, in per-
microgram of RNA, there was greater signal for the miRNA microarray when we used ‘small
RNA’ derived from the Ambion MiRVANA kit.
It is noteworthy that the total RNA isolation techniques did not appear biased toward any RNA
that was also present in the large RNA samples. This is an important bias to rule out, but may
be differentially present or absent in different profiling platforms.
This study demonstrates that identifying an optimal RNA isolation technique for miRNA
microarray studies is non-trivial. Whether or not there is a conventionally-assumed “gold
standard”, we feel that there is no absolute standard for miRNA expression profiling. We have
received (as yet unpublished) accounts from a number of colleagues describing discrepant
results from different profiling modalities (microarrays, Northern blots, PCR, sequencing),
and, even theoretically, this is not surprising, because each would be predicted to have unique
biases. In our hands, different profiling platforms can have differential sensitivities to specific
miRNAs. For example, relative to the microarray experiments, the Northern blots “report” a
higher relative amount of miR-26a, and a lower relative amount of miR-221. Furthermore, the
Northern blot also showed a greater degree of constancy in the results, irrespective of the RNA
isolation technique. By contrast, microarray results appeared to vary more according to which
RNA isolation technique was used. This was not apparently due to the presence or absence of
larger miRNA precursors in the total RNA isolation samples, because the techniques for
isolating only larger RNA fragments (RNEasy and Ambion large RNA isolation) did not detect
miRNA signals that were present in the total RNA isolation techniques but absent using the
small RNA isolation techniques. In fact, miRNA profiles using the total RNA isolation
techniques (Trizol LS and Stratagene total RNA isolation) appeared to have a relatively robust
correlation with Northern blotting.
Our interpretation of these results provide the basis for some recommendations for isolating
RNA for miRNA expression profiling:
1. It is important to be methodologically consistent across different tissues and samples;
never compare RNA against each other that were isolated using different techniques.
2. When ‘positive’ findings are indicated by miRNA microarray, they must be carefully
validated using different modalities.
3. The various biases of each technique should be investigated (including for Northern
blots!).
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4. When reporting the results of a microarray experiment, the methods involved in RNA
isolation should be carefully documented.
In addition to studying the effects of the RNA isolation technique per se, this study provided
some insights into the significance of the cell and tissue variables in assessing neural tissues.
One aspect of these studies involved a comparison between primary cultures of rat E15–18
neurons and astrocytes. The miRNA repertoires of these cell types showed differences. Some
of these differences have been reported previously in an excellent study by Smirnova et al
[43]. Specifically, these researchers reported that miR-23a and miR-26a were highly enriched
in astrocytes, whereas mir-124a and miR-128 were specific to neurons. We and others have
also previously shown that miR-124a is selectively expressed in neurons [44,45]. These results
give an added measure of confidence in the degree to which these results can be generalized.
We also found differences in the miRNA profiles in the gray matter and the white matter that
is immediately underlying gray matter. Gray matter and white matter are terms that are used
to distinguish areas in the CNS. Gray matter includes neurons and white matter is the domain
with a preponderance of myelinated axons and oligodendrocytes. Many astrocytes are present
in both gray matter and white matter. As a practical consideration, the junction between gray
matter and white matter is not absolutely distinct, and particularly in some portions of the
cerebral cortex (e.g., motor cortex) the transition can be impossible to delineate exactly.
However, in the present context, the question is whether it is important to dissect away – and/
or analyze separately – the white matter even in a relatively small sample of human brain
(deeper white matter may be expected to have a more clear-cut difference in expression
profiles). Our results, showing that gray matter and superficial white matter have differences
in miRNA expression, are at least partly due to the different cell types that are present in gray
versus white matter, the latter having more oligodendrocytes and less neurons. This outcome
would probably differ across distinct areas of the cerebral cortex, for practical reasons such as
the fact that in temporal cortex there are greater numbers of neurons within white matter than
in many other areas of the cerebral cortex.
Taken together, the finding of different miRNA profiles in primary cultures of neurons versus
astrocytes, and also the difference between gray matter and nearby white matter, provides
specific considerations for dissection of CNS tissue for RNA isolation in the context of miRNA
microarrays:
1. When comparing different tissue types, it is important to consider the biases inherent
to tissues with different ratios of neurons to glial cells (e.g. gliomas versus normal
brain, or infarctions versus non-infarcted tissue).
2. An important difference between mature neuronal and glial cells are that only the
latter tend to divide, and so some of the miRNA expression differences between them
may subserve either promoting (glia) or suppressing (neurons) cell division.
3. Dissect away white matter from gray matter, as it will increase the specificity of the
results; for this reason it is logical to have the dissection performed by a person with
expertise.
4. As we have reported previously [45], tissue-level miRNA microarray analyses should,
where possible, be complemented with cellular and subcellular level analyses (in situ
hybridization) of particular miRNAs.
Prior studies have focused upon the impact of RNA isolation variables, in the context of mRNA,
but, miRNAs may have different stability issues. For example, miRNAs appear to be more
stable in formalin-fixed, paraffin-embedded tissue than are mRNAs [32,42]. Many unresolved
issues remain. For example, the impact of premortem variables (for example, patients being
treated with morphine, or chemotherapy, or other highly biologically active medication?; or,
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pre-mortem pain or stress?). Also, post-mortem effects (post-mortem interval, tissue pH, tissue
homogenization variables, and freezing and thawing) may be important. The relative sensitivity
and specificity differences among the various miRNA profiling techniques may lead to
discrepant results. It is imperative to further investigate the significance of these variables to
lay a solid foundation for further studies.
It must be acknowledged that the study of miRNAs in the brain is in its infancy, and the
technical aspects of miRNA isolation for expression profiling is likewise in an early stage.
These issues merit further study. This does not of course preclude obtaining very interesting –
and possibly biologically and/or medically important -- results with currently available miRNA
expression profiling technology.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Correlating the results between the six different RNA isolation techniques that are expected to
include microRNAs. These comparisons show that distinct RNA isolation methods result in
different miRNA profiling results. These data also may help to predict which of the techniques
is most able to provide results that correlate with the outcomes of other methods. Correlations
were performedusing linear regression in comparing the results of three different microarray
experiments (biological replicates). Representative comparisons are depicted in Figs 1A and
1B. . The results of cross-comparisons between all the techniques is presented in Fig 1C. The
RNA isolation methods shown here are, respectively, the Stratagene Total RNA, Stratagene
small RNA, Ambion Total RNA, Ambion Small RNA, Trizol LS per provided protocol, and
Trizol LS with added −20C overnight precipitation step added. For Fig. 1C, each method is
compared against each other on the left, using linear regression, in which higher correlation is
depicted in red, and lower in gray. For each of the individual RNA isolation methods, the
columns to the right of Fig 1C show the method which most closely correlates to that method;
the median degree of correlation (R-squared; highest highlighted in yellow); and the average
degree of correlation (highest highlighted in yellow). In sum, the overall R-squared are
generally >0.90 but the correlations are highest between RNA samples that are designed to
obtain total RNA with phenol/chloroform extraction (such as in Fig A). Small RNA isolating
techniques show lower degree of correlation, as shown in Fig B.
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Figure 2.
The microarray and Northern results were not identical, and show that RNA isolation methods
will impact differently on different profiling platforms. The top chart is microarray data for
miR-26a, miR-29a, Let-7a, and miR-221. The bottom chart relates the data for miRNA
expression from the same RNA samples via Northern blot. The microarray and Northern blot
data are presented in Supplementary File 5. All the RNA was obtained as technical replicates.
The microarray data represents the results of three different microarrays, the Northern blots a
single experiment each. Two important differences can be seen relating the microarray results
to Northern blots: firstly, the Northern blots appear to be relatively more sensitive for miR-26a,
but less sensitive for miR-221 in all cases. Secondly, the overall pattern of expression is similar
for between the RNA isolation techniques in the Northern blots. However, for the microarray
results, the pattern varied for the different RNA isolation methods, which indicates that for this
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microarray platform the results are more sensitive (than Northern blots)to the RNA isolation
method used.
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Figure 3.
Neurons and astrocytes express distinct subsets of miRNAs and this can be used to help
‘genotype’ a human cell line. A comparison of rat E15–18 derived primary cortical cultures—
hippocampal neurons versus cerebral cortical astrocytes—shows that each has a relatively
different miRNA repertoire. Each data point represents a particular miRNA, correlating the
microarray single intensity from 3 combined and averaged microarray experiments each. Note
that there is a very poor correlation (R2 correlation coefficient = 0.034; blue diamonds) between
the miRNA expression profile of these primary cultured cells. Human H4 glioneuronal cancer
line cells show a far better correlation with cultured primary rat astrocytes (R2= 0.48; red
squares) than primary cultured rat neurons (R2=.016; data not shown).
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Figure 4.
Human gray matter and white matter express different miRNA repertoire, which poses a
challenge to tissue sampling of human cerebral cortex. These figures comparing miRNA
profiles derived from RNA isolated from gray matter (GM) and superficial white matter (sWM;
as opposed to deep white matter dWM) of human brain (gross coronal section for illustration’s
purposes). MiRNAs from GM and sWM from the superior and middle temporal cortex from
three different human patients were compared. These biological replicates tended to have a
high degree of expression correlation across different miRNAs when gray matter was compared
with gray matter, or white matter to white matter, from different patients. However, when
miRNA profiles were compared between white matter and gray matter (whether within or
between patients) there was less correlation. Figs 4 C–E are charts that show the correlation in
miRNA expression for representative cases of gray matter and white matter. Note that the
correlation in Figs 4 C and D are tighter in comparison to Fig 4E, despite the fact that only
figure 4E is comparing the miRNA profiling results within the same patient.
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Table 2
Microarray signals from cells in culture for comparison’s sake
The miRNAs expressed in rat primary E15–E18 cultures show a differing expression profile for cortical neurons and
astrocytes. The highly-expressed miRNAs are shown. The human H4 glioneuronal cell line shows an expression profile
that is not exactly like either rat primary cell type, however, it more closely resembles the rat astrocytes. These data
represent three technical replicates each.
Primary rat astrocytes Primary rat neurons H4 cells
miR-124b 12.3 2924.5 380.6
miR-124a 18.2 3805.5 414.5
miR-20 22.1 44.7 94.8
miR-128 33.6 420.6 108.9
miR-219 35.3 147.4 108.5
miR-151* 76.7 67.9 206.1
miR-213 155.2 163.9 314.7
miR-16 168.7 87.8 201.0
miR-100 208.6 177.2 750.2
miR-320 222.0 152.4 712.0
miR-143 266.0 28.2 119.3
miR-143a 288.4 49.7 119.3
miR-99a 328.0 374.3 557.5
miR-145 334.2 97.7 211.2
miR-26a 358.9 149.0 181.5
miR-99 (ctrl) 370.1 433.9 555.7
miR-181a 382.8 458.7 270.0
miR-107 397.7 546.5 326.3
miR-27 429.2 51.3 873.7
miR-22 430.8 67.9 225.5
miR-125a 460.1 329.5 899.8
miR-193 526.4 13.2 169.3
miR-23b 576.7 67.9 1347.5
let-7a 629.2 1338.0 2098.4
miR-24-1,2 706.9 89.4 864.6
miR-23a 861.6 89.4 1592.0
miR-29 1035.2 144.1 1120.0
miR-221 1135.4 127.5 1364.3
miR-21 1662.4 97.7 2359.3
let-7bL 2101.5 1424.2 1824.9
miR-125b 3146.6 2121.3 1406.8
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Table 3
miRNAs that are more expressed in either gray matter or white matter in human temporal lobe isocortex (n=3
for WM, n=6 for GM).
A comparison between human temporal lobe cerebral cortical tissue from gray matter (GM) and from white matter
(WM) shows some miRNAs that are relatively concentrated in GM or WM. The particular miRNAs that are shown
are from among the 50 miRNAs that are show highest expression in human brain. Those with a GM/WM ratio <0.75
or >1.5 are shown. These results indicate the importance of technical expertise in sampling tissue from human cerebral
cortex for miRNA expression profiling.
GM/WM
White matter concentrated Ratio
miR-100 0.49
miR-151* 0.50
miR-213 0.51
let-7bL 0.53
miR-23b 0.62
miR-191 0.66
miR-181a 0.68
miR-320 0.72
miR-342 0.73
Gray matter concentrated
miR-143 1.65
miR-145 1.74
miR-124 1.83
miR-29a 1.89
miR-172 1.98
miR-185 2.09
miR-128a 2.16
miR-143 2.23
miR-128ash 2.27
miR-128b 2.31
miR-126 2.39
miR-145sh 2.48
miR-29b 2.87
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